global DL-methionine market and secures the best possible supply security for our customers.” The conversion and expansion of the


AB VISTA BROADENS GUT-HEALTH PORTFOLIO WITH PRODUCT


ACQUISITION AB Vista has extended its product offering with the acquisition of Progres®


, a natural


additive from Finnish biosciences company Hankkija.


Progres® is a patented natural resin


acids product that improves gut integrity by reducing inflammation and stimulates tissue recovery with a healing effect. It also beneficially modulates intestinal microbiota, favouring butyrate producers and lactobacilli, reducing the growth of Gram-positive pathogens. First developed in 2015, Progres®


improves performance in poultry, swine and ruminants, and is an important part of antibiotic-free production systems. AB Vista’s Managing Director Juan Ignacio Fernández said: “Progres®


is an


exciting natural product based on strong research and scientific background that supports a more sustainable approach to animal production, so fits well with our whole ethos at AB Vista. “Adding Progres®


to our portfolio


expands the support we can provide nutritionists, veterinarians and production managers, looking for strategies and production programmes that deliver improved gut health, nutritional optimisation, and food safety & security. This acquisition also demonstrates our commitment to growing our offer into the wider additives market.”


EVONIK INVESTS €25M IN METHIONINE


PRODUCTION PLANT UPGRADE


IN WESSELING/GERMANY Evonik has invested €25 million developing and expanding its methylmercapto- propionaldehyde (MMP) production plant in Wesseling, Germany, in the latest move to strengthen its world-scale global methionine production network. MMP is integral in the production of (DL-methionine) which is used


MetAMINO®


in animal feed to improve the performance of livestock farming. The precursors of this essential amino acid have been produced in Wesseling for more than 50 years. Dr. Gaetano Blanda, head of Animal


Nutrition business line, said: “With this investment, Evonik is strengthening the European methionine network to safeguard the long-term supply of MMP to our MetAMINO®


Belgium. The move underscores our commitment to serving and expanding the


PAGE 54 MARCH/APRIL 2023 FEED COMPOUNDER


plant in Wesseling has been made possible by the development of a new production process that will allow Evonik to avoid the storage of chemical intermediates, such as acrolein, at the site. Commenting on the plant upgrade,


Dr. Jan-Olaf Barth, head of the Essential Nutrition product line, said: “Evonik is known for its innovative approach and world-class technology, and in Wesseling we have now developed a process that increases efficiency and, with Responsible Care in mind, further enhances safety at the site.” He added: “This investment is a building


block of our global methionine asset strategy with the clear goal of being the cost and technology leader in all regions, and the reliable partner for our customers.”


BACTOCELL AUTHORISED IN EU AS A TECHNOLOGICAL


ADDITIVE First lactic acid bacteria to receive an authorisation related to the hygiene of liquid feed Lallemand Animal Nutrition announces its unique lactic acid bacteria strain Pediococcus acidilactici CNCM I-4622 (Bactocell) has been authorised in the European Union as a technological feed additive in the functional group of acidity regulators and of hygiene condition enhancers. The authorisation is for use in all animal


species (REGULATION (EU) 2023/53). Bactocell was already recognised by the European Food Safety Authority (EFSA) for its safety and potential to reduce pH and limit growth of coliform bacteria in liquid feeds.


Authorisation covers the application INTERMEDIATES


of the lactic bacteria in mash compound feeds and/or solid feed materials used for the preparation of liquid feeds at a minimum inclusion level of 1x109


(colony-forming


units) CFU/kg feed. This is the first lactic acid bacteria to receive such an authorisation related to the hygiene of liquid feed. In Europe, liquid feed is particularly


popular for swine in countries including Ireland, where more than 70% of finishers — as well as the majority of sows — are fed liquid feed. Ensuring the sanitary quality of liquid feed and the feeding system itself is a key priority for producers. David Saornil, product manager for


production hub in Antwerp,


Swine Application at Lallemand Animal Nutrition, commented: “We are very pleased with this new authorisation that validates the benefits of Bactocell as a solution to improve liquid feed quality in sows, fattening pigs and piglets. Bactocell was already recognised for its probiotic benefits on gut health. We continue to document our benefits to producers and the industry as a whole.”


EVONIK MULTIPLIES PRODUCTION CAPACITY FOR


PROBIOTICS Evonik has modernised and expanded probiotics production at its site in León, Spain, laying the foundations for further growth in the Gut Health Solutions business. The capacity for producing Ecobiol®


, Fecinor® and GutCare® has been


more than doubled. The León site can now produce the equivalent of 6,000 metric tons of blended final probiotic product per year. With a stronger focus on probiotic-


based alternatives to antibiotic growth promoters, Evonik’s Animal Nutrition business line aims to provide solutions that ensure the well-being and performance of the animal while protecting human health and supplying a growing world population with high-quality animal protein. “Providing sustainable solutions for


improving animal health and well-being is a matter close to our hearts, and at the same time a strategically important growth business for Evonik,” says Gaetano Blanda, head of Evonik’s Animal Nutrition business line. “With this expansion in León comes the ability to meet the growing demand for our probiotics product line. We will continue to demonstrate the impact of our solutions on the microbiome, gut function, and animal performance.” Probiotics are living microorganisms


added to animal feed to maintain or restore the microbial balance in the animals’ intestines. “As long as there are enough ‘good’ bacteria to keep potential pathogens at bay, an animal remains healthy,” explains Torben Madsen, head of Sustainable Healthy Nutrition at Evonik Animal Nutrition. “A stable gut microbiota also strengthens the animal’s immune system, helping to prevent disease.” Evonik Animal Nutrition has


developed an innovative portfolio of Gut Health Solutions based on probiotics for swine, poultry and aquaculture. Its probiotics line – from the fermentation of active microorganisms to the finished feed additive and pre-blends – have been manufactured in León since 2016. The site has been developed and optimised continuously. In 2022, Evonik has invested in


state-of-the-art fermentation capacities, a new cooling circuit system and a new warehouse at the site, which became operational recently. In addition to boosting production


capacity, the new facilities and improved processes bring important sustainability improvements for the company. Energy, fresh water and raw material use per product have been significantly reduced and, since January 2023, the site has been using electricity exclusively from renewable energy sources.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68